Hudson Bay Capital Management’s NLS Pharmaceutics Warrant NLSPW Stock Holding History

Hudson Bay Capital Management’s Portfolio NLSPW Stock Details NLSPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-71,356	Closed	-$821	–	1423
2024 Q4	$821	Hold	71,356	–	–	﹤0.01%	902
2024 Q3	$1.11K	Sell	71,356 -28,644	-29%	-$842	﹤0.01%	828
2024 Q2	$3.01K	Hold	100,000	–	–	﹤0.01%	741
2024 Q1	$4.9K	Hold	100,000	–	–	﹤0.01%	674
2023 Q4	$5.61K	Hold	100,000	–	–	﹤0.01%	645
2023 Q3	$10.5K	Hold	100,000	–	–	﹤0.01%	709
2023 Q2	$10.2K	Hold	100,000	–	–	﹤0.01%	751
2023 Q1	$15K	Hold	100,000	–	–	﹤0.01%	751
2022 Q4	$27.7K	Hold	100,000	–	–	﹤0.01%	802
2022 Q3	$25K	Hold	100,000	–	–	﹤0.01%	1032
2022 Q2	$12K	Hold	100,000	–	–	﹤0.01%	1221
2022 Q1	$38K	Sell	100,000 -100,000	-50%	-$35.5K	﹤0.01%	1041
2021 Q4	$165K	Hold	200,000	–	–	﹤0.01%	921
2021 Q3	$154K	Hold	200,000	–	–	﹤0.01%	888
2021 Q2	$192K	Hold	200,000	–	–	﹤0.01%	852
2021 Q1	$190K	Buy	+200,000	New	+$182K	﹤0.01%	781

Other funds holding NLSPW

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Hudson Bay Capital Management's NLSPW Position: Q1 2025 in Review

Hudson Bay Capital Management sold out of NLS Pharmaceutics Warrant (NLSPW) in Q1 2025, closing a stake of 71,356 shares — an estimated $821 sold.

Hudson Bay Capital Management first reported a position in NLSPW in Q1 2021 and held it in 16 quarters. The position peaked at $192K in Q2 2021. 3 funds tracked by Wall St. Rank hold NLSPW as of Q1 2025.

Hudson Bay Capital Management reported no remaining NLS Pharmaceutics Warrant position as of Q1 2025 after selling out during the quarter.
Hudson Bay Capital Management sold 71,356 NLS Pharmaceutics Warrant shares in Q1 2025, an estimated $821.
Hudson Bay Capital Management first reported a position in NLS Pharmaceutics Warrant in Q1 2021 and held it in 16 quarters.
Hudson Bay Capital Management's NLS Pharmaceutics Warrant position peaked at $192K in Q2 2021.
3 funds tracked by Wall St. Rank held NLS Pharmaceutics Warrant as of Q1 2025.

Based on Hudson Bay Capital Management's 13F filing for Q1 2025, filed 14 May 2025.